Ascendis Pharma (ASND) cash on hand

Cash · fiscal 2025
€616.04M

Ascendis Pharma (ASND) held cash of €616.04M at the end of fiscal 2025 (December 31, 2025). That is 10.1% higher than the €559.54M of fiscal 2024. Figures as of 18 Nov 2026, 01:12 UTC, from Yahoo Finance.

Key facts

Cash, fiscal 2025
€616.04M
Change on fiscal 2024
+10.1%
Highest on record
€735.46Mfiscal 2022
Lowest on record
€399.44Mfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

Ascendis Pharma cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €735.46M in fiscal 2022 and the lowest €399.44M in fiscal 2023.

History · 4 fiscal years

Cash by fiscal year

Ascendis Pharma cash on hand, year by year

Ascendis Pharma (ASND) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025€616.04M 10.1% up
2024€559.54M 40.1% up
2023€399.44M 45.7% down
2022€735.46M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Ascendis Pharma and comparable companies
CompanyCashFiscal year
Revvity RVTY$919.86M2025
Exelixis EXEL$1.06B2025
Neurocrine Biosciences NBIX$1.48B2025
Ascendis Pharma ASND€616.04M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ASND

Ascendis Pharma, figure by figure

Ascendis Pharma (ASND) overview: price, valuation and scorecardAll health care companies by market value

Ascendis Pharma cash on hand: questions and answers

How much cash does Ascendis Pharma have?

Ascendis Pharma (ASND) held cash of €616.04M at the end of fiscal 2025 (December 31, 2025). That is 10.1% higher than the €559.54M of fiscal 2024.

What are the highest and lowest cash figures on record for Ascendis Pharma?

Across the 4 fiscal years on record (2022–2025), the highest was €735.46M in fiscal 2022 and the lowest €399.44M in fiscal 2023.

How is Ascendis Pharma's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ascendis Pharma (ASND) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/ASND/cash

Underlying data: Yahoo Finance.